CIK: 1624830 - Address: C/O Quince Therapeutics, Inc., 611 Gateway Blvd, Suite 273, South San Francisco, CA 94080
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/22/24 17:51
8/20/24
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagRyan Charles S.CAOPP310.650004865122D
12/17/15 10:25
12/7/15
BRTXBiorestorative Therapies, Inc.NVHealthHealthMisc Health & Allied ServicesRyan Charles S.NYDP.d254.00066316D
5/12/15 16:37
5/8/15
BRTXBiorestorative Therapies, Inc.NVHealthHealthMisc Health & Allied ServicesRyan Charles S.NYDP.d500.25000200New200D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact